Institutional

*Our private-equity approach to investing at times can uncover opportunities in private companies which go public. In seeking to achieve its investment objective, the Strategy may, from time to time, opportunistically invest in these companies whose securities are issued in an initial public offering (“IPO”). We may sell these securities over a short period of time due to the amount of securities allocated, our analysis of intrinsic value and return prospects or liquidity requirements.

**Our core turnover, since composite inception is 30.37%, as of March 31, 2022. “Core turnover” is a component of Portfolio Turnover, the statistic calculated in accordance with SEC regulation. We define “core turnover” as turnover that results in the introduction of a new holding or a substantial liquidation (over 90%) of an existing holding. It differs from Portfolio Turnover in that it does not include trims or additions to the existing holdings. In other words, core turnover plus trims and adds equals Portfolio Turnover. The Strategy’s Since Composite Inception SEC Portfolio Turnover, as of March 31, 2022 is 102.83%

¹May access a stock in an emerging, frontier or other market through an equity total return swap (TRS). May invest in an equity offering (IPO, primary, secondary, rights, private etc.)

²Active share indicates the proportion of the portfolio’s holdings (by market value) that are different than the benchmark. A higher active share indicates a larger difference between the benchmark and the portfolio.

The Global Emerging Markets Equity Composite includes all discretionary accounts with market values greater than $1 million managed by Loomis Sayles that seek to produce long-term excess returns at or below benchmark risk over a full market cycle relative to the MSCI Emerging Markets Index and generally within the market capitalization range of the Index. In seeking to achieve its investment objective, the Composite’s strategy may, from time to time, opportunistically invest in companies whose securities are issued in an initial public offering (“IPO”). The investment performance of the Composite during periods when it invests in IPOs may be higher than during periods without IPO participation. Contribution from IPOs may not be repeated, particularly as the Composite’s assets grow. There is no assurance that the Composite can and will continue to participate in IPOs. The Composite inception date is December 1, 2019. The Composite was created in 2019.

Performance data shown represents past performance and is no guarantee of, and not necessarily indicative of, future results. Current performance may be lower or higher than quoted. Returns are shown in US dollars and are annualized for one and multi-year periods. Gross returns are net of trading costs. Net returns are gross returns less effective management fees.

There is no guarantee that the investment objective will be realized or that the strategy will generate positive or excess return.


In seeking to achieve its investment objective, the Strategy may, from time to time, opportunistically invest in companies whose securities are issued in an initial public offering (“IPO”). We may sell these securities over a short period of time due to the amount of securities allocated, our analysis of intrinsic value and return prospects or liquidity requirements. For the period ending March 31, 2022, the Strategy’s IPO holdings contributed -0.33%, 0.08%, 0.08% 10.32%, 3.86% for the month of March, first quarter, year to date, one year and since inception (annualized), respectively. Contribution from IPOs may not be repeated, particularly as the Strategy’s assets grow. There is no assurance that the Strategy can and will continue to participate in IPOs. The investment performance of the Strategy during periods when it invests in IPOs may be higher than during periods without IPO participation.